XML 26 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
SIGNIFICANT ACQUISITIONS
12 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
SIGNIFICANT ACQUISITIONS ACQUISITIONS
Acquisition of Innovative Food Processors, Inc.
On June 1, 2017, the Company acquired 100 percent of the outstanding common shares of Innovative Food Processors, Inc. (“IFP”), a privately held manufacturer of agglomerated and microencapsulated food and nutrition ingredients, headquartered in Faribault, Minnesota. The Company made payments of approximately $22,975 on the acquisition date and $635 in September to true-up working capital, amounting to approximately $16,161 to the former shareholders, adjustments for working capital acquired of $5,065, and $2,384 to IFP’s lenders to pay off all IFP bank debt. The acquisition of IFP expands the Company’s Human Nutrition & Health segment’s processing technology and market reach, while bringing innovative and value-added systems to food, beverage, and nutrition customers.
Management has completed its accounting for the acquisition. As a result, the fair values of the assets acquired and liabilities assumed have been determined and $1,340 of estimated goodwill has been recorded.
The following table summarizes the fair values of the assets acquired and liabilities assumed:
Cash and cash equivalents
 
$
5,065

Accounts receivable
 
2,860

Inventories
 
2,537

Prepaid expenses
 
186

Property, plant and equipment
 
12,219

Customer relationships
 
2,942

Developed technology
 
1,078

Trademark & trade name
 
1,388

Covenant not to compete
 
126

Goodwill
 
1,340

Trade accounts payable
 
(844
)
Accrued expenses
 
(1,416
)
Bank debt
 
(2,384
)
Deferred income taxes
 
(3,871
)
Amount paid to shareholders
 
21,226

IFP bank debt paid on purchase date
 
2,384

Total amount paid
 
$
23,610


The goodwill of $1,340 arising from the IFP Acquisition consists largely of expected synergies, including the combined entities’ experience and technical problem solving capabilities, and acquired workforce. The goodwill is assigned to the Human Nutrition & Health segment, and is not tax deductible for income tax purposes.
The valuation of the fair value of tangible and intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions. In preparing the Company's fair value of the intangible assets and certain tangible assets acquired, management, among other things, consulted an independent advisor. Additionally, certain intangible assets are not tax deductible.
Customer relationships are amortized over a 10-year period utilizing an accelerated method based on the estimated average customer attrition rate. Trademark, trade name, covenant not to compete, and developed technology are amortized over 10 years, 5 years, 3 years, and 5 years, respectively, utilizing the straight-line method as the consumption pattern of the related economic benefits cannot be reliably determined.
The Company is indemnified for tax liabilities prior to the acquisition date. Indemnified tax liabilities will create an indemnification asset (receivable). At this time, an indemnification asset (receivable) balance has not been established.

The Company also completed one immaterial acquisition in 2017, Chol-Mix Kft, and another immaterial acquisition in 2018, Bioscreen Technologies Srl.

Transaction and integration costs related to recent acquisitions are included in general and administrative expenses and amounted to $1,786 and $2,163 for the years ended December 31, 2018 and 2017, respectively.